Funds and ETFs Catalent, Inc.

CTLT

US1488061029

Name	Weight	AuM	1st Jan change	Investor Rating
REVERE SECTOR OPPORTUNITY ETF - USD	0.03%	6 M€	+17.98%	-
AGILITY SHARES MANAGED RISK ETF - USD	0.03%	0 M€	+6.97%	-
HSBC MSCI USA UCITS ETF - USD	0.02%	0 M€	+11.62%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR	0.02%	786 M€	-.--%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD	0.02%	23 M€	-.--%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR ETF - USD	0.02%	0 M€	+6.85%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.02%	0 M€	+8.24%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.02%	284 M€	-.--%
NIGHTSHARES 500 1X/1.5X ETF - USD	0.02%	14 M€	+16.19%	-
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.02%	206 M€	-.--%
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR	0.02%	0 M€	+5.79%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.02%	0 M€	+5.63%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR	0.02%	273 M€	-.--%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.02%	655 M€	-.--%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD	0.02%	1,174 M€	+23.54%
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	0 M€	+2.80%	-
AMUNDI INDEX MSCI WORLD UCITS ETF - EUR	0.01%	1,166 M€	+0.26%
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.01%	607 M€	+0.05%
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.01%	0 M€	+8.70%	-
ASYMMETRIC SMART ALPHA S&P 500 ETF - USD	0.01%	1 M€	-.--%
ADAPTIVE RH TACTICAL OUTLOOK ETF - USD	0.01%	0 M€	+9.18%	-
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	0 M€	+0.50%	-
ADAPTIVE RH HEDGED MULTI-ASSET INCOME ETF - USD	0.01%	0 M€	+4.20%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR	0.01%	0 M€	+3.50%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR	0.01%	29 M€	-.--%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR	0.01%	322 M€	+13.88%

Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: - provision of development services and clinical supply services (55.4%); - subcontracted manufacturing services (44.6%). Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).

Sector

Pharmaceuticals

Calendar

2024-05-28 - Extraordinary Shareholders Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Catalent, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

55.81 USD

Average target price

63.5 USD

Spread / Average Target

+13.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CATALENT, INC.	+24.22%	10.1B
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:01 2024-05-10 pm EDT			5-day change	1st Jan Change
55.81 ^USD	-0.30%		-1.22%	+24.22%

May. 09	MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	RE
May. 08	Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B	MT